BioNTech looking into taking legal steps against CureVac

CureVac NV

06/07/2022 14:04

BERLIN, July 6 (Reuters) - BioNTech  22UAy.DE  is looking
into taking legal steps against CureVac  5CV.DE  after the
latter filed a patent lawsuit against it over its use of mRNA
technology, BioNTech said on Wednesday, confirming a report by
daily Welt. 
    "We are looking at all legal options," said a BioNTech
spokesperson. 
    CureVac is seeking "fair compensation" from BioNTech and two
subsidiaries for infringement of its intellectual property
rights, it said on Tuesday. 
    BioNTech has said in reaction that its work was original and
it would defend it against all allegations of patent
infringement.  urn:newsml:reuters.com:*:nL8N2YM300
    

 (Reporting by Kirsti Knolle and Patricia Weiss
Editing by Miranda Murray)
 ((kirsti.knolle@thomsonreuters.com;))